X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (228) 228
Publication (44) 44
Book Review (35) 35
Conference Proceeding (30) 30
Book Chapter (9) 9
Book / eBook (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (138) 138
index medicus (124) 124
humans (110) 110
female (62) 62
male (62) 62
lung neoplasms - drug therapy (61) 61
carcinoma, non-small-cell lung - drug therapy (54) 54
aged (53) 53
middle aged (48) 48
lung cancer (42) 42
chemotherapy (41) 41
adult (38) 38
cancer (34) 34
antineoplastic agents - therapeutic use (32) 32
lung neoplasms - pathology (32) 32
immunotherapy (31) 31
antineoplastic combined chemotherapy protocols - therapeutic use (30) 30
article (29) 29
treatment outcome (28) 28
carcinoma, non-small-cell lung - pathology (26) 26
neoplasm staging (24) 24
aged, 80 and over (23) 23
nivolumab (23) 23
antibodies, monoclonal - therapeutic use (22) 22
care and treatment (22) 22
ipilimumab (21) 21
bevacizumab (20) 20
lung cancer, non-small cell (20) 20
survival (20) 20
docetaxel (19) 19
lung neoplasms - mortality (19) 19
neoplasms - drug therapy (19) 19
patients (18) 18
respiratory system (18) 18
safety (16) 16
antineoplastic agents - adverse effects (15) 15
carcinoma, non-small-cell lung - mortality (15) 15
mutation (15) 15
open-label (15) 15
survival rate (15) 15
abridged index medicus (14) 14
antibodies, monoclonal - administration & dosage (14) 14
antibodies, monoclonal - adverse effects (14) 14
lung neoplasms - immunology (14) 14
medicine & public health (14) 14
non-small cell lung cancer (14) 14
prognosis (14) 14
research (14) 14
apoptosis (13) 13
cell lung-cancer (13) 13
drug therapy (13) 13
lung neoplasms - genetics (13) 13
melanoma (13) 13
mutations (13) 13
trial (13) 13
tumors (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
carboplatin (12) 12
dose-response relationship, drug (12) 12
carcinoma, non-small-cell lung - genetics (11) 11
expression (11) 11
gefitinib (11) 11
gemcitabine (11) 11
medicine, general & internal (11) 11
original reports (11) 11
paclitaxel (11) 11
pd-1 (11) 11
programmed cell death 1 receptor - antagonists & inhibitors (11) 11
solid tumors (11) 11
antineoplastic agents - pharmacology (10) 10
blockade (10) 10
carboplatin - administration & dosage (10) 10
carcinoma, non-small-cell lung - immunology (10) 10
pembrolizumab (10) 10
quality of life (10) 10
therapy (10) 10
animals (9) 9
antibodies, monoclonal, humanized (9) 9
clinical trials as topic (9) 9
cohort studies (9) 9
disease-free survival (9) 9
dosage and administration (9) 9
erlotinib (9) 9
immunotherapy - methods (9) 9
lung neoplasms - therapy (9) 9
paclitaxel - administration & dosage (9) 9
pd-l1 (9) 9
phase-ii (9) 9
programmed cell death 1 receptor - immunology (9) 9
survival analysis (9) 9
analysis (8) 8
cancer therapies (8) 8
carcinoma (8) 8
cisplatin (8) 8
combination (8) 8
double-blind (8) 8
follow-up studies (8) 8
multicenter (8) 8
non-small-cell lung cancer (8) 8
pd-l1 protein (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2007, 1, Translational medicine series, ISBN 9780849390210, Volume 3, viii, 265
Lung cancer is the leading cause of cancer-related deaths in the United States. Filling a gap in the literature, this resource translates recent laboratory... 
Chemotherapy | Treatment | drug therapy | Lungs | Antineoplastic Agents | Technological innovations | Lung Neoplasms | Molecular aspects | therapeutic use | Cancer | Oncology | Pulmonary Medicine | Lungs - Cancer - Molecular aspects
Book
New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 10, p. 997
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2018, Volume 36, Issue 26, pp. 2744 - 2744
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2015, Volume 373, Issue 17, pp. 1627 - 1639
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 19, pp. 1823 - 1833
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 21, pp. 1976 - 1986
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 26, pp. 2443 - 2454
Releasing T cells from inhibitory control has been a strategy exploited by the anti–CTLA-4 antibody ipilimumab. Now an antibody against a second checkpoint... 
CELL LUNG-CANCER | MEDICINE, GENERAL & INTERNAL | THERAPY | SOLID TUMORS | RESPONSE CRITERIA | IMMUNOTHERAPY | GUIDELINES | B7 FAMILY | B7-H1 | ANTITUMOR IMMUNITY | BLOCKADE | Neoplasms - metabolism | Antibodies, Monoclonal - pharmacology | Humans | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - metabolism | Antibodies, Monoclonal - therapeutic use | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Neoplasms - drug therapy | Dose-Response Relationship, Drug | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Melanoma - drug therapy | Adult | Female | Ligands | Antineoplastic Agents - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Programmed Cell Death 1 Receptor - immunology | Carcinoma, Renal Cell - drug therapy | Prostatic Neoplasms - drug therapy | Drugs | Dose-response relationship (Biochemistry) | Immune response | Anti-antibodies | Dosage and administration | Product/Service Evaluations | Regulation | Research | Drug therapy | Cancer | Fees & charges | Kidneys | Stock options | PD-1 protein | Laboratories | Toxicity | Tumor cells | Body weight | Lung cancer | Colorectal carcinoma | Colorectal cancer | Melanoma | Licenses | Lymphocytes T | Patients | Castration | PD-L1 protein | Antitumor activity | Prostate cancer | Drug dosages | Prostate | Clear cell-type renal cell carcinoma | Tumors | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
2011, John Hopkins patients' guide, ISBN 9780763774363
Web Resource